⚠️ High Alert Medication

Dopamine Infusion

Syringe pump continuous infusion preparation (4,000 mcg/mL), dose-dependent hemodynamic titration, and extravasation surveillance protocol.

Syringe Pump Infusion Preparation (Standard Concentration)

Ampoule Presentation 5 mL ampoule (40 mg/mL of dopamine hydrochloride)
Dopamine Dose 200 mg (5 mL = one 5 mL ampoule)
Compatible Diluent 45 mL of D5W or 0.9% Sodium Chloride (NS)
Final Syringe Volume 50 mL
Final Concentration 4,000 mcg/mL (4 mg/mL)
Stability 24 hours at room temperature

Materials Required

  • Dopamine ampoule 40 mg/mL (5 mL) × 1
  • 60 mL Luer-lock syringe
  • 0.9% Sodium Chloride (NS) or 5% Dextrose (D5W)
  • Sterile drawing-up needle / filter needle
  • Dedicated syringe pump infusion label
  • Extension line (100 cm)
  • Alcohol chlorhexidine swabs

Preparation Procedure (Aseptic Non-Touch Technique)

  1. Verification: Verify the written physician order, patient identity, body weight, and clinical indication.
  2. Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
  3. Ampoule Check: Check the dopamine ampoule for:
    • Correct drug and strength, dopamine hydrochloride (40 mg/mL)
    • Expiry date
    • Container integrity, clarity, and absence of precipitate or discoloration
  4. Withdrawal: Open one ampoule of dopamine. Withdraw 5 mL into a 60 mL Luer-lock syringe (Total dopamine drawn: 5 mL = 200 mg dopamine).
  5. Dilution: Add 45 mL of 0.9% Sodium Chloride or D5W to a final volume of 50 mL.
  6. Mixing: Gently invert the syringe several times to ensure uniform mixing.
  7. Visual Inspection: Inspect solution to ensure it is clear, colorless, and free of visible particles. A pink, yellow, or brown tint indicates drug decomposition; discard the syringe.
  8. Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
  9. Syringe Pump Setup: Prime the extension set, install into the syringe pump, and shield from excessive ambient light.

🔒 Lumen Policy: Dopamine is inactivated in alkaline solutions (sodium bicarbonate, aminophylline, furosemide) and is incompatible with numerous medications. It must be infused via a dedicated central venous catheter lumen whenever possible.

⚠️ Peripheral Administration: In an emergency situation, dopamine may be infused peripherally through a large proximal vein for short-term bridging use only, with frequent site monitoring for extravasation.

Dose-Dependent Receptor Effects

Dopamine's hemodynamic effect changes with dose. Thresholds overlap and vary considerably between patients, so titrate to clinical response rather than to a fixed tier.

Low Dose (Dopaminergic)

< 2–5 mcg/kg/min
  • D1 receptor stimulation: renal and splanchnic vasodilation
  • "Renal-dose" dopamine is not recommended; it does not prevent or treat acute kidney injury

Intermediate Dose (Inotropic)

2–10 mcg/kg/min
  • β1 stimulation: increased contractility, heart rate, and cardiac output
  • Useful for symptomatic bradycardia unresponsive to atropine

High Dose (Vasopressor)

10–20 mcg/kg/min
  • α1 stimulation: systemic vasoconstriction, raised SVR and blood pressure
  • Marked rise in tachyarrhythmia risk and myocardial oxygen demand

Administration & Titration

Recommended Dosing Parameters

  • Administration Route: Administer via syringe pump; dedicated central line lumen preferred.
  • Recommended Starting Dose: 2 to 5 mcg/kg/min (titrate infusion to achieve desired hemodynamic result).
  • Titration Step: Increase by 1 to 4 mcg/kg/min every 10 to 30 minutes according to response.
  • Symptomatic Bradycardia: 5 to 20 mcg/kg/min, titrated to heart rate and blood pressure response.
  • Maximum Dose: 20 mcg/kg/min. If further support is needed, add or switch to an alternative vasopressor under intensivist supervision.
  • Hypovolemia: Correct intravascular volume depletion before or during initiation.
  • Weaning: Taper gradually; abrupt discontinuation may cause marked hypotension.
  • Syringe Continuity: Do not allow the infusion to run out. A syringe can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
  • Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes discoloured, cloudy, or contaminated.

Hemodynamic Monitoring Requirements

  • Monitor arterial blood pressure continuously (invasive arterial line preferred).
  • Monitor heart rate and continuous ECG rhythm for sinus tachycardia, atrial fibrillation, and ventricular ectopy.
  • Observe for chest pain or ECG changes suggesting myocardial ischemia.
  • Monitor for peripheral tissue ischemia or necrosis, particularly at high doses.
  • Assess end-organ perfusion markers (urine output, mental status, peripheral pulse volume, serum lactate).

Clinical Cautions

  • Septic Shock: Noradrenaline is the preferred first-line vasopressor; dopamine is associated with more arrhythmias.
  • MAO Inhibitors: Effects markedly prolonged and intensified; a substantially reduced starting dose is required.
  • Contraindicated: Pheochromocytoma and uncorrected tachyarrhythmias or ventricular fibrillation.

Extravasation Surveillance & Response Protocol

Extravasation of dopamine causes severe local vasoconstriction leading to ischemic sloughing and necrosis.

Normal Infusion Site

  • No cutaneous blanching
  • No local swelling
  • No pain, burning, or stinging
  • No tissue discolouration

Extravasation Suspected:

  1. STOP infusion immediately (do not flush line).
  2. Notify clinician promptly.
  3. Aspirate residual drug through the cannula if possible, then remove catheter.
  4. Document event in patient clinical record.

Dopamine Infusion Rate Chart (4,000 mcg/mL)

Shows equivalent dose in mcg/kg/min for a given pump rate (mL/hr) across patient weights. Central venous line administration preferred.

Rate
(mL/hr)
Weight (Kg) and Dose (mcg/kg/min)
40 kg 45 kg 50 kg 55 kg 60 kg 65 kg 70 kg 75 kg 80 kg 85 kg 90 kg 95 kg 100 kg
11.71.51.31.21.11.01.00.90.80.80.70.70.7
23.33.02.72.42.22.11.91.81.71.61.51.41.3
35.04.44.03.63.33.12.92.72.52.42.22.12.0
46.75.95.34.84.44.13.83.63.33.13.02.82.7
58.37.46.76.15.65.14.84.44.23.93.73.53.3
610.08.98.07.36.76.25.75.35.04.74.44.24.0
711.710.49.38.57.87.26.76.25.85.55.24.94.7
813.311.910.79.78.98.27.67.16.76.35.95.65.3
915.013.312.010.910.09.28.68.07.57.16.76.36.0
1016.714.813.312.111.110.39.58.98.37.87.47.06.7
1118.316.314.713.312.211.310.59.89.28.68.17.77.3
1220.017.816.014.513.312.311.410.710.09.48.98.48.0
1321.719.317.315.814.413.312.411.610.810.29.69.18.7
1423.320.718.717.015.614.413.312.411.711.010.49.89.3
1525.022.220.018.216.715.414.313.312.511.811.110.510.0
1626.723.721.319.417.816.415.214.213.312.511.911.210.7
1728.325.222.720.618.917.416.215.114.213.312.611.911.3
1830.026.724.021.820.018.517.116.015.014.113.312.612.0
1931.728.125.323.021.119.518.116.915.814.914.113.312.7
2033.329.626.724.222.220.519.017.816.715.714.814.013.3
2135.031.128.025.523.321.520.018.717.516.515.614.714.0
2236.732.629.326.724.422.621.019.618.317.316.315.414.7
2338.334.130.727.925.623.621.920.419.218.017.016.115.3
2440.035.632.029.126.724.622.921.320.018.817.816.816.0
2541.737.033.330.327.825.623.822.220.819.618.517.516.7
2643.338.534.731.528.926.724.823.121.720.419.318.217.3
2745.040.036.032.730.027.725.724.022.521.220.018.918.0
2846.741.537.333.931.128.726.724.923.322.020.719.618.7
2948.343.038.735.232.229.727.625.824.222.721.520.419.3
3050.044.440.036.433.330.828.626.725.023.522.221.120.0
Within usual range (≤ 20 mcg/kg/min) Exceeds 20 mcg/kg/min maximum

Infusion Conversion (Solution Concentration 4,000 mcg/mL)

Standard equations for a 4,000 mcg/mL solution (200 mg in 50 mL):

Infusion Rate (mL/hr):

Rate (mL/hr) = [ Dose (mcg/kg/min) × Weight (kg) × 60 ] / 4000

Shortcut: Rate = Dose × Weight × 0.015
Infusion Dose (micrograms/kg/minute):

Dose (mcg/kg/min) = [ Rate (mL/hour) × Concentration (4000 mcg/mL) ] / [ Weight (kg) × 60 ]

'Shortcut' example: 70 kg patient at 5 mcg/kg/min → 5 × 70 × 0.015 = 5.25 mL/hr.

© criticalcareinsights.com. All rights reserved. For clinical reference and educational use only.